ResearchPod Summary
The persistence of the HIV-1 reservoir remains a major barrier to a cure. While 'Shock-and-Kill' strategies rely on the ability of cytolytic T lymphocytes (CTLs) to identify and eliminate infected cells after viral reactivation, it is unclear if reservoir cells possess intrinsic, stable resistance to cell death. This study investigates whether HIV-1-infected CD4+ T cells are inherently less susceptible to CTL-mediated lysis compared to their uninfected counterparts.
The researchers developed an ex vivo killing assay using CTL-engaging single-chain diabodies (scDbs). These molecules bind simultaneously to CD3 on T cells and a target peptide presented on MHC class I (or HLA-E) on the surface of target cells, forcing a potent cytotoxic response regardless of the CTL's natural antigen receptor specificity. They applied this to freshly isolated CD4+ T cells from people living with HIV on suppressive antiretroviral therapy and also tested acutely infected cells expressing various HIV-1 reporter constructs, specifically examining the role of the viral protein Nef.
The researchers found no evidence of a general, intrinsic resistance to CTL killing in reservoir cells from donors on therapy; infected cells were killed at rates comparable to uninfected bystander cells. While actively infected cells appeared to have a survival advantage, this was not due to an inherent resistance to the cell-killing machinery itself. Instead, the viral protein Nef actively downregulates surface MHC class I molecules (such as HLA-A2), reducing antigen presentation and shielding the cell from CTL recognition. When the CTL response was redirected to the stable non-classical MHC molecule HLA-E—which is not affected by Nef—infected cells were as susceptible to killing as uninfected cells.
These findings indicate that the HIV-1 reservoir is not protected by a broad, intrinsic cellular resistance to death pathways. The perceived 'resistance' of infected cells is largely a strategy of immune evasion (reducing visibility) rather than survival under attack. This suggests that therapeutic interventions capable of overcoming antigen downregulation or ensuring consistent target visibility could effectively engage the immune system to clear the reservoir, as the downstream execution mechanisms of CTL-mediated lysis remain fully functional against infected cells.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.